<!DOCTYPE html>
<html lang="en" dir="ltr">
    <head>
        <meta charset="utf-8">
        <link rel="stylesheet" href="style.css">
        <title> Omnibuster Section </title>
    </head>

    <body>
        <div class="section">
            <h1> Section s3853 </h1>
            <p> <section id="d3355e27893" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3853" style="-uslm-lc:I650144"><num value="3853">SEC. 3853. </num><heading>DRUGS EXCLUDED FROM THE OVER-THE-COUNTER DRUG REVIEW.</heading><subsection class="indent0 fontsize10" id="d3355e27898" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3853/a" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="a">(a) </num><heading><inline class="small-caps">In General</inline>.—</heading><content>Nothing in this Act (or the amendments made by this Act) shall apply to any nonprescription drug (as defined in section 505G(q) of the Federal Food, Drug, and Cosmetic Act, as added by section 3851 of this subtitle) which was excluded by the Food and Drug Administration from the Over-the-Counter Drug Review in accordance with the paragraph numbered 25 on page 9466 of volume 37 of the Federal Register, published on May 11, 1972.</content>
</subsection>
<subsection class="indent0 fontsize10" id="d3355e27909" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3853/b" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="b">(b) </num><heading><inline class="small-caps">Rule of Construction</inline>.—</heading><content>Nothing in this section shall be construed to preclude or limit the applicability of any other provision of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/t21/s301/etseq">21 U.S.C. 301 et seq.</ref>).</content>
</subsection>
</section></p>
        </div>  
    </body>